NIH SIREN Neurologic Clinical Trials (U01 Clinical Trial Required)
The summary for the NIH SIREN Neurologic Clinical Trials (U01 Clinical Trial Required) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
NIH SIREN Neurologic Clinical Trials (U01 Clinical Trial Required): This funding opportunity announcement (FOA) encourages applications for multi-center clinical trials focused on neurological emergencies. Successful applicants will collaborate and conduct the trial within the NIH SIREN Network. The NIH SIREN Clinical Coordinating Center (CCC) will work with the successful applicants to implement the proposed trial efficiently and the SIREN Data Coordinating Center (DCC) will provide statistical and data management support. The NIH SIREN hubs and their affiliated clinical sites will provide on-site implementation of the clinical protocols.
Federal Grant Title: | NIH SIREN Neurologic Clinical Trials (U01 Clinical Trial Required) |
Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PAR-18-304 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.837, 93.838, 93.839, 93.853 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | January 7th, 2021 |
Original Application Deadline: | January 7th, 2021 |
Posted Date: | October 3rd, 2017 |
Creation Date: | October 3rd, 2017 |
Archive Date: | February 12th, 2021 |
Total Program Funding: | |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
Last Updated: | October 3rd, 2017 |
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
- Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/pa-files/PAR-18-304.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster - Similar Government Grants
- • Phased Multi-Site Clinical Trial: Testing Prevention of Cardiovascular Disease in Young Ad...
- • Phased Multi-Site Clinical Trial: Testing Prevention of Cardiovascular Disease in Young Ad...
- • Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24 Clinical Trial Not...
- • Limited Competition for Continuation of the Prospective Study of Chronic Kidney Disease in...
- • Limited Competition for Continuation of the Prospective Study of Chronic Kidney Disease in...
- • The Relationship Between Hypertension and Inflammation
- • Community-Responsive Interventions to Reduce Cardiovascular Risk in American Indians and A...
- • Weight Loss in Obese Adults with Cardiovascular Risk Factors: Clinical Interventions (U01)
- More Grants from the National Institutes of Health
- • Urology Centers Program Interactions Core (U24 Clinical Trial Not Allowed)
- • Coordinating Center to Support Consortium for Neuroscience Alzheimers Disease (AD) and AD-...
- • Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials o...
- • Administrative Supplements to Promote Diversity in Research and Development Small Business...
- • Organs-on-a-Chip in Dental, Oral, and Craniofacial Research (DOC-OoCs) (R21 Clinical Trial...